(Q73443447)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11179859%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Misconceptions in the debate on the iron hypothesis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11179859%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

J L. Sullivan

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11179859%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11179859%20AND%20SRC:MED&resulttype=core&format=json

Journal of Nutritional Biochemistry

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11179859%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11179859%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11179859%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

33-37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11179859%20AND%20SRC:MED&resulttype=core&format=json

Iron and the sex difference in heart disease risk

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Iron versus cholesterol--perspectives on the iron and heart disease debate

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Iron and the genetics of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Iron status and the risk of coronary heart disease: an example of the use of nutritional epidemiology in chronic disease research

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Iron, atherosclerosis, and ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Serum iron level, coronary artery disease, and all-cause mortality in older men and women.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Increased Risk of Acute Myocardial Infarction in Carriers of the Hemochromatosis Gene Cys282Tyr Mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Dietary iron intake and risk of coronary disease among men

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Antiproliferative effect of desferrioxamine on vascular smooth muscle cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Iron overload augments the development of atherosclerotic lesions in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Iron-mediated radical reactions upon reperfusion contribute to myocardial "stunning".

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Decrease of myocardial infarct size with desferrioxamine: possible role of oxygen free radicals in its ameliorative effect

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Iron chelation in myocardial preservation after ischemia-reperfusion injury: the importance of pretreatment and toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Effects of deferoxamine on H2O2-induced oxidative stress in isolated rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Maintenance of left ventricular function (90%) after twenty-four-hour heart preservation with deferoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Metal Ion Release from Mechanically-Disrupted Human Arterial Wall. Implications for the Development of Atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Deferoxamine, an iron chelator, reduces myocardial injury and free radical generation in isolated neonatal rabbit hearts subjected to global ischaemia-reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Coronary venous retroinfusion of deferoxamine reduces infarct size in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Colocalization of iron and ceroid in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Effects of Hydroxyethyl Starch Conjugated Deferoxamine on Myocardial Functional Recovery Following Coronary Occlusion and Reperfusion in Dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Spermine prevent iron accumulation and depress lipofuscin accumulation in cultured myocardial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Iron and atherosclerosis: inhibition by the iron chelator deferiprone (L1)

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Studies of hypoxemic/reoxygenation injury: without aortic clamping. IV. Role of the iron-catalyzed pathway: deferoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Iron-Dependent Human Platelet Activation and Hydroxyl Radical Formation

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Transferrin delays oxygen radical induced cardiac-contractile failure

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Lipid-induced changes in intracellular iron homeostasis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Treatment with deferoxamine during ischemia improves functional and metabolic recovery and reduces reperfusion-induced oxygen radical generation in rabbit hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Iron in human atheroma and LDL oxidation by macrophages following erythrophagocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

Iron-mediated cardiovascular injury

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2800%2900142-X

7 January 2021

10.1016/S0955-2863(00)00142-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11179859%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference